MD492Y - Metodă de determinare a răspândirii cancerului gastric de tip intestinal - Google Patents
Metodă de determinare a răspândirii cancerului gastric de tip intestinal Download PDFInfo
- Publication number
- MD492Y MD492Y MDS20110142A MDS20110142A MD492Y MD 492 Y MD492 Y MD 492Y MD S20110142 A MDS20110142 A MD S20110142A MD S20110142 A MDS20110142 A MD S20110142A MD 492 Y MD492 Y MD 492Y
- Authority
- MD
- Moldova
- Prior art keywords
- gastric cancer
- spread
- determining
- intestinal type
- type gastric
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Invenţia se referă la medicină, în special la oncologie şi poate fi utilizată pentru determinarea răspândiri cancerului gastric de tip intestinal.Conform invenţiei metoda constă în aceea că după stabilirea tipului de cancer gastric se efectuează analizele serologice şi se determină markerii CA 19-9, CA 125, antigenul carcinomului embrionar, gonadotropina corionică umană, numărul de T-limfocite citotoxice CD3 şi T-helperi CD4, în cazul, în care markerul CA 19-9 constituie 50,0…200,0 UI/ml, CA 125 - 35,0…500,0 UI/ml, antigenul carcinomului embrionar - 7,0…15,0 ng/ml, gonadotropina corionică umană - 18…287 ng/ml, T-limfocite citotoxice CD3 - 28…54%, iar T-helperi CD4 - 10…20%, se stabileşte răspândirea cancerului gastric de tip intestinal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20110142A MD492Z (ro) | 2011-08-17 | 2011-08-17 | Metodă de determinare a răspândirii cancerului gastric de tip intestinal |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20110142A MD492Z (ro) | 2011-08-17 | 2011-08-17 | Metodă de determinare a răspândirii cancerului gastric de tip intestinal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD492Y true MD492Y (ro) | 2012-03-31 |
| MD492Z MD492Z (ro) | 2012-10-31 |
Family
ID=45929358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20110142A MD492Z (ro) | 2011-08-17 | 2011-08-17 | Metodă de determinare a răspândirii cancerului gastric de tip intestinal |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD492Z (ro) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110484624B (zh) * | 2019-08-28 | 2021-01-26 | 南京大学 | 一种基于外周血的胃癌生物标志物及其检测方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3222G2 (ro) * | 2006-03-22 | 2007-08-31 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Metodă de diagnostic al cancerului endometrial |
| MD3717G2 (ro) * | 2008-03-21 | 2009-05-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Metodă de diagnostic diferenţiat al tumorilor glandei mamare |
-
2011
- 2011-08-17 MD MDS20110142A patent/MD492Z/ro not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD492Z (ro) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019502484A1 (en) | Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereof | |
| AU2018236742B2 (en) | Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same | |
| PH12019500193A1 (en) | Chimeric antigen receptors targeting bcma and methods of use thereof | |
| CY1118668T1 (el) | Ανοσοσυζευγματα εναντι υποδοχεα φολικου οξεος 1 και χρησεις αυτων | |
| WO2019033043A3 (en) | Anti-cd8 antibodies and uses thereof | |
| CY1122161T1 (el) | Συζευγμενα αντισωματα anti-cd38 | |
| CL2016002359A1 (es) | Anticuerpos que se une al receptor de crecimiento epidermal humano (anti-egfr) y conjugados de anticuerpo anti-egfr y fármaco | |
| NZ591882A (en) | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers | |
| MX2017014083A (es) | Polipeptido de fusion anti-cancer. | |
| CO2017001921A2 (es) | Anticuerpos anti-cll-1 e inmunoconjugados | |
| BR112016009402A2 (pt) | Peptídeo, linfócitos t citotóxicos (ltc) ativados, método para sua produção, anticorpo, receptor de células t, ácido nucleico, célula hospedeira, uso dos mesmos, kit, método para produzir uma vacina anticâncer personalizada para um paciente individual | |
| EP3885366A3 (en) | Therapeutic antibodies against ror-1 protein and methods for use of same | |
| TN2017000203A1 (en) | Antibodies against cd73 and uses thereof | |
| PH12020550598A1 (en) | Methods and compositions for dosing of allogeneic chimeric antigen receptor t cells | |
| WO2015200828A8 (en) | Conjugates for immunotherapy | |
| MX2016007865A (es) | Peptidos citotoxicos y conjugados de los mismos. | |
| MY169147A (en) | Drug-protein conjugates | |
| WO2014008206A3 (en) | DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF HLA-E MONOSPECIFIC MONOCLONAL IgG ANTIBODIES DIRECTED AGAINST TUMOR CELL SURFACE AND SOLUBLE HLA-E | |
| MX2021005085A (es) | Formulacion de anticuerpo. | |
| MX2019009121A (es) | Antcuerpos anti-kaag1 o fragmento de union al antigeno del mismo para el tratamiento de cancer de mama triple negativo. | |
| SG11201910113PA (en) | Plasmin-cleavable anti-insoluble fibrin antibody-drug conjugate | |
| WO2013170263A3 (en) | Dosage and administration of bispecific scfv conjugates in combination with anti-cancer therapeutics | |
| MD492Y (ro) | Metodă de determinare a răspândirii cancerului gastric de tip intestinal | |
| WO2016191703A3 (en) | Tumor deliverable iron and protein synthesis inhibitors as a new class of drugs for the diagnosis and treatment of cancer | |
| GB201100804D0 (en) | Drug combination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) | ||
| MM4Y | Short-term patent definitely lapsed due to non-payment of fees |